'Supplementary figure s1' diaporamas de présentation

Respiration rate (nmol O 2 /min/mg protein). Succinate ( mM ).

SUPPLEMENTARY FIGURES

Supplementary Figures. Supplementary Figure S1. siControl. pcDNA3. siControl. pcDNA3. BRCA1wt. siBRCA1. BRCA1wt. siBRCA1. MDA-MB-231. Proliferation. A. *. ***. 120. ***. **. *. ***. 100. **. ***. ***. ***. 80. ***. ***. cells in S+G2/M (% of control). 60. 40. 20.

Nishioka et al. supplementary Figure S1. Nrf2 (whole tissue). 54 kDa. β -actin. Nrf2 (cytosol). 54 kDa. tubulin. Nrf2 (nuclei). 54 kDa. Lamin A. 1.0. Nrf2/Lamin A. 0.5. wild-type sham. wild-type IPC. p21-KO sham. p21-KO IPC. Nishioka et al. supplementary Figure S2.

Supplementary figure S1. Normoxia PBS. Hypoxia antagomiR-20a. Hypoxia antagomiR_MM. Hypoxia PBS. Normoxia PBS. Hypoxia antagomiR-20a. Hypoxia antagomiR_MM. Hypoxia PBS. 01. 02. 04. 13. 14. 20. 03. 26. 27. 05. 06. 12. 21. 22. 28. 29. 09. 17. 18. 19. 25. 30. 10.

A. Supplementary Figure S1. B. Supplementary Figure S1. C. Supplementary Figure S1. D. Supplementary Figure S1. D. A. our 5' cluster > 5ppm 32,808. GIS-RNA-PET 5' cluster > 5ppm 7,564. 6,503. B. C. GIS-RNA-PET 3' cluster > 5ppm 7,624. our 3' cluster > 5ppm 42,945.

Padmalatha et al., Supplementary Figure 1. Gel pictures. Electopherogrames. Total RNA. Fluorescent value. Complementary RNA (cRNA). Fluorescent value. Fragmented cRNA. Fluorescent value. Size of the peak.

Supplementary Figure S1 Wang et. al. Pre-sort. Post-sort. a. 10 5. 4.12. 0.07. 10 4. WT. 10 3. 10 2. 0. 10 5. 5.47. 0.16. 10 4. Bim /. 10 3. 10 2. CD25. 0. 0. 10 2. 10 3. 10 4. 10 5. 0. 10 2. 10 3. 10 4. 10 5. Foxp3. b. Bim /. WT. 10 5. 10 4. 10 3. 10 2.

5S. 5S+33. 5S+I. 5S – trnR. molar excess AS5-3. 0. 250. 500. 0. 250. 500. 0. 250. 500. 0. 250. 500. AS5-3. Supplementary Figure S1. competitor. petD ∆ 50. AS5-1. Supplementary Figure S2. WT. rne. pnp1-1. rnr1-3. VIGS rnj. Supplementary Figure S3.

A. -DFB. +DFB. KW103. KW128. KW133. DA003. DA018. Supplementary figure S1. DFB-dependent bacterial colony morphotypes (A) and pigment formation (B). The growth conditions are the same as in Fig. 1. B. -DFB. +DFB. KW001. KW003. KW122. Supplementary figure S1, continued.

Supplementary figure S1 1 H NMR spectrum of promomycin (CD 3 OD, 500 MHz). Supplementary figure S2 13 C NMR spectrum of promomycin (CD 3 OD, 125 MHz). Supplementary figure S3 DQFCOSY spectrum of promomycin. Supplementary figure S4 HMQC spectrum of promomycin.

Supplementary Figure S1. Bss S I digested pXL-BacII-SmHSP70-Luc. Bss S I digested pXL-BacII-SmAct-Luc. Bss S I. 5171 bp. 6072 bp. Bss S I. Bss S I. Bss S I. 5’IR. 3’IR. 5’IR. 3’IR. HSP70. Luciferase SV40. Actin. Luciferase SV40. Bss S I. Bss S I. Bss S I. Bss S I. 1390 bp.

CT lvOSM. Supplementary figure S1. A. 10 12. lvOSM. CT. C. 10 10. ALP. Cell numbers. BSP. 10 8. OC. 10 6. sclerostin. 10 4. 0. 10. 20. 30. 40. 50. Days post transduction. B. E11. *. DMP1. 1600. 1200. Phex. caspase 3 activity (arbitrary units). 800. 18S. 400. 0.

Supplementary figure S1. B. nestin. A. 100  m. D. C. E. GFAP. MAP2. GalC. H. F. MAP2. G. GFAP. nestin.

Supplementary Figure S1. Activation levels of Src (p- Src ) are not correlated with mTOR pathway activation (p-S6) across multiple breast cancer subtypes. y = 0.1721x + 3.4499 R 2 = 0.0405.

Supplementary Figure S1. 30.50 28.50 26.50 24.50 22.50 18.50 16.50 15.93. Slope:-3.273 R 2 : 0.980. Ct. 2 3 4 5 6. Log ( mmoX copy number per reaction).

Supplementary figure S1. Supplementary figure S2. A. B. DNA replication %. DNA replication %. NU. EB+NU. EB. ctl. 20’ 60’. 20’ 60’. 20’ 60’. 20’ 60’. cdc45. RPA. PCNA. MCM3. Supplementary figure S3. A. B. DNA replication %. Supplementary figure S4. % DNA replicated.

pAWF-DIAP1. CG7023. CG5384. CG5603. CG7288. CG12082. CG8830. CG5798. CG5505. CG8494. CG4165. CG30421. CG3781. CG4968. CG9448. CG14884. vec. pAMW. 150. 150. 100. 100. 75. 75. 50. 50. FLAG (DIAP1). 37. 37. 25. 25. 20. 20. Actin. Yang et al. Supplementary Figure S1.

Supplementary figure S1.